General

Showing 49–64 of 2270 results

Article: A-108 MONITORING ISSUES OF DIRECT ANTI-XA ORAL ANTICOAGULANTS AND LOW MOLECULAR WEIGHT HEPARINS, DURING BRIDGING WITH LMWH THERAPY
€3.03 Add to cart
Article: A-108 N-ACETYLCYSTEINE IN PRECLINICAL ANIMAL MODELS OF THROMBOTIC THROMBOCYTOPENIC PURPURA
€3.03 Add to cart
Article: A-109 A PATIENT WITH ACQUIRED FACTOR X DEFICIENCY AND METASTATIC TRANSITIONAL CELL CARCINOMA OF THE BLADDER : IS THERE A LINK BETWEEN METASTASIS AND FACTOR DEFICIENCY IN SOLID TUMOURS?
€3.03 Add to cart
Article: A-109 UNRESTRAINED ENDOGENOUS PLASMIN ACTIVITY REVERSES ACUTE THROMBOTIC THROMBOCYTOPENIC PURPURA
€3.03 Add to cart
Article: A-111 CLOPIDOGREL PREVENTS COLITIS-ASSOCIATED CARCINOGENESIS IN MICE BY INHIBITING IMMUNOSUPPRESSIVE FUNCTION OF IMMATURE MYELOID CELLS
€3.03 Add to cart
Article: A-111 IMPACT OF A RAPID CENTRIFUGATION METHOD ON THE ACCURACY OF DIRECT ORAL ANTICOAGULANTS LEVEL AND TURNAROUND TIME
€3.03 Add to cart
Article: A-111 Recombinant ADAMTS13 as an effective therapy for acquired thrombotic thrombocytopenic purpura in rats
€3.03 Add to cart
Article: A-112 ABSENCE OF PEAR1 DOES NOT AFFECT MURINE PLATELET FUNCTION
€3.03 Add to cart
Article: A-112 Causes of ‘Gray platelets’: from genetic studies of inherited thrombocytopenia to functional studies
€3.03 Add to cart
Article: A-113 PREVENTABILITY OF SERIOUS ADVERSE DRUG REACTIONS RELATED TO THE USE OF DIRECT ORAL ANTICOAGULANTS: A PROSPECTIVE STUDY
€3.03 Add to cart
Article: A-114 von Willebrand factor-binding protein exhibits a dual role in bacterial adhesion to the vessel wall
€3.03 Add to cart
Article: A-115 ACQUIRED VON WILLEBRAND SYNDROME AFTER LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION
€3.03 Add to cart
Article: A-116 EVALUATION OF THE CLINICAL PERFORMANCE OF TWO AUTOMATED IMMUNOASSAYS IN THE DIAGNOSIS OF THROMBOTIC ANTIPHOSPHOLIPID SYNDROME
€3.03 Add to cart
Article: A-116 Influence of platelet count in platelet rich plasma for adenosine triphosphate release assay
€3.03 Add to cart
Article: A-117 GARP DEFICIENCY IN MURINE PLATELETS OR ENDOTHELIAL CELLS DOES NEITHER AFFECT HEMOSTASIS NOR THROMBOSIS
€3.03 Add to cart
Article: A-118 PERFORMANCES EVALUATION OF A NEW COAGULATION ANALYSER, STA R MAX® 2
€3.03 Add to cart

Article: A-108 MONITORING ISSUES OF DIRECT ANTI-XA ORAL ANTICOAGULANTS AND LOW MOLECULAR WEIGHT HEPARINS, DURING BRIDGING WITH LMWH THERAPY

Article: A-108 N-ACETYLCYSTEINE IN PRECLINICAL ANIMAL MODELS OF THROMBOTIC THROMBOCYTOPENIC PURPURA

Article: A-109 A PATIENT WITH ACQUIRED FACTOR X DEFICIENCY AND METASTATIC TRANSITIONAL CELL CARCINOMA OF THE BLADDER : IS THERE A LINK BETWEEN METASTASIS AND FACTOR DEFICIENCY IN SOLID TUMOURS?

Article: A-109 UNRESTRAINED ENDOGENOUS PLASMIN ACTIVITY REVERSES ACUTE THROMBOTIC THROMBOCYTOPENIC PURPURA

Article: A-111 CLOPIDOGREL PREVENTS COLITIS-ASSOCIATED CARCINOGENESIS IN MICE BY INHIBITING IMMUNOSUPPRESSIVE FUNCTION OF IMMATURE MYELOID CELLS

Article: A-111 IMPACT OF A RAPID CENTRIFUGATION METHOD ON THE ACCURACY OF DIRECT ORAL ANTICOAGULANTS LEVEL AND TURNAROUND TIME

Article: A-111 Recombinant ADAMTS13 as an effective therapy for acquired thrombotic thrombocytopenic purpura in rats

Article: A-112 ABSENCE OF PEAR1 DOES NOT AFFECT MURINE PLATELET FUNCTION

Article: A-112 Causes of ‘Gray platelets’: from genetic studies of inherited thrombocytopenia to functional studies

Article: A-113 PREVENTABILITY OF SERIOUS ADVERSE DRUG REACTIONS RELATED TO THE USE OF DIRECT ORAL ANTICOAGULANTS: A PROSPECTIVE STUDY

Article: A-114 von Willebrand factor-binding protein exhibits a dual role in bacterial adhesion to the vessel wall

Article: A-115 ACQUIRED VON WILLEBRAND SYNDROME AFTER LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION

Article: A-116 EVALUATION OF THE CLINICAL PERFORMANCE OF TWO AUTOMATED IMMUNOASSAYS IN THE DIAGNOSIS OF THROMBOTIC ANTIPHOSPHOLIPID SYNDROME

Article: A-116 Influence of platelet count in platelet rich plasma for adenosine triphosphate release assay

Article: A-117 GARP DEFICIENCY IN MURINE PLATELETS OR ENDOTHELIAL CELLS DOES NEITHER AFFECT HEMOSTASIS NOR THROMBOSIS

Article: A-118 PERFORMANCES EVALUATION OF A NEW COAGULATION ANALYSER, STA R MAX® 2